scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1048859846 |
P356 | DOI | 10.1186/1471-2164-8-98 |
P932 | PMC publication ID | 1858692 |
P698 | PubMed publication ID | 17425807 |
P5875 | ResearchGate publication ID | 51389980 |
P50 | author | Ravi Kiran Reddy Kalathur | Q55755978 |
Takashi Takahashi | Q56945207 | ||
P2093 | author name string | Paturu Kondaiah | |
Prathibha Ranganathan | |||
Aravinda K Chavalmane | |||
Animesh Agrawal | |||
Raghu Bhushan | |||
P2860 | cites work | Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription | Q24311810 |
Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis | Q24679619 | ||
Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue | Q24685525 | ||
Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line | Q24802607 | ||
Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts | Q24804612 | ||
DAVID: Database for Annotation, Visualization, and Integrated Discovery | Q27499374 | ||
Regulation of Smad signaling by protein kinase C | Q28205657 | ||
Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
How cells read TGF-beta signals | Q29619993 | ||
Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2. | Q30471974 | ||
Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses | Q30476201 | ||
Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis | Q33868837 | ||
TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway | Q33890533 | ||
Association of mitogen-activated protein kinase with the microtubule cytoskeleton | Q33934584 | ||
Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225) | Q33937674 | ||
Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines | Q34416684 | ||
Non-Smad TGF-beta signals | Q34443708 | ||
Function of cytokines within the TGF-beta superfamily as determined from transgenic and gene knockout studies in mice | Q34663767 | ||
Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. | Q34792468 | ||
Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects | Q34792580 | ||
Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells | Q35038917 | ||
The two faces of transforming growth factor beta in carcinogenesis | Q35170231 | ||
PI3K/Akt signalling pathway and cancer. | Q35692250 | ||
Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression. | Q36035342 | ||
Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta | Q36218283 | ||
Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta | Q36232185 | ||
Alterations in components of the TGF-beta superfamily signaling pathways in human cancer | Q36323395 | ||
Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. | Q36564164 | ||
Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. | Q38302488 | ||
Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFB1. | Q38357026 | ||
TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells | Q38516130 | ||
Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. | Q40243334 | ||
Identification of apoptotic genes mediating TGF-beta/Smad3-induced cell death in intestinal epithelial cells using a genomic approach | Q40244813 | ||
The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. | Q40437776 | ||
Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-beta1 in rat proximal tubular cells and mouse fibroblasts. | Q40457216 | ||
Differential activation of Smads in HeLa and SiHa cells that differ in their response to transforming growth factor-beta | Q40546736 | ||
alpha(v)beta(3) Integrin interacts with the transforming growth factor beta (TGFbeta) type II receptor to potentiate the proliferative effects of TGFbeta1 in living human lung fibroblasts | Q40547538 | ||
Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene | Q40559849 | ||
Fetal liver stroma consists of cells in epithelial-to-mesenchymal transition | Q40680236 | ||
Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway | Q40874515 | ||
Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells | Q40998147 | ||
Establishment of human peripheral lung epithelial cell lines (HPL1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor beta1. | Q41081957 | ||
Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells | Q41083036 | ||
Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer | Q41195958 | ||
Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts | Q43550271 | ||
Integrin-linked kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition | Q44814280 | ||
Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity | Q45405811 | ||
Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts | Q46815041 | ||
Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors | Q48445033 | ||
Increasing complexity of Ras signaling. | Q53429989 | ||
Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction | Q69588815 | ||
Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture | Q69936661 | ||
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells | Q70377223 | ||
The effect of TGF-beta1 on differential gene expression profiles in human corneal epithelium studied by cDNA expression array | Q74114723 | ||
Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma | Q83289786 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 98 | |
P577 | publication date | 2007-04-11 | |
P1433 | published in | BMC Genomics | Q15765854 |
P1476 | title | Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells | |
P478 | volume | 8 |
Q35631181 | Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer |
Q37258607 | Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells |
Q34532301 | Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis |
Q54641807 | Activin A induces a non-fibrotic phenotype in smooth muscle cells in contrast to TGF-β. |
Q45395864 | Association between endogenous feline leukemia virus loads and exogenous feline leukemia virus infection in domestic cats |
Q34986181 | Can systems biology understand pathway activation? Gene expression signatures as surrogate markers for understanding the complexity of pathway activation |
Q36565065 | Co-transfection of decorin and interleukin-10 modulates pro-fibrotic extracellular matrix gene expression in human tenocyte culture |
Q38899586 | Context dependent non canonical WNT signaling mediates activation of fibroblasts by transforming growth factor-β. |
Q53497674 | Differential effect of TGFβ on the proteome of cancer associated fibroblasts and cancer epithelial cells in a co-culture approach - a short report. |
Q28075996 | Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity |
Q33748854 | Effects of PPAR gamma ligands on TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial cells. |
Q88930977 | Elevated transforming growth factor β signaling activation in β-actin-knockout mouse embryonic fibroblasts enhances myofibroblast features |
Q36531360 | Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells. |
Q33698618 | Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin |
Q37698171 | FGF-2, TGFbeta-1, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: an in vivo and in vitro study. |
Q41674050 | Gene Regulation Network Based Analysis Associated with TGF-βeta Stimulation in Lung Adenocarcinoma Cells |
Q29614591 | Genetics of gene expression and its effect on disease |
Q57297592 | Genome-Wide Investigation of Genes Regulated by ERα in Breast Cancer Cells |
Q36545600 | Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma |
Q34411687 | Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor β Signaling Pathway with Smad2 and IκB Kinase α in squamous cell carcinoma |
Q39036986 | Insulin like growth factor binding protein 4 promotes GBM progression and regulates key factors involved in EMT and invasion |
Q91329734 | Integration of TGF-β-induced Smad signaling in the insulin-induced transcriptional response in endothelial cells |
Q61798333 | Iron and liver fibrosis: Mechanistic and clinical aspects |
Q33564214 | Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma |
Q39680878 | MicroRNA-23b-3p regulates human keratinocyte differentiation through repression of TGIF1 and activation of the TGF-ß-SMAD2 signalling pathway. |
Q38214771 | Mysteries of TGF-β Paradox in Benign and Malignant Cells |
Q36571451 | Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer. |
Q28476479 | Phenocopy--a strategy to qualify chemical compounds during hit-to-lead and/or lead optimization |
Q38957062 | Primary Cilia and Coordination of Receptor Tyrosine Kinase (RTK) and Transforming Growth Factor β (TGF-β) Signaling |
Q35531840 | Protein kinase Cα mediates erlotinib resistance in lung cancer cells |
Q39101381 | Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3. |
Q37279377 | Quantitative modeling and analysis of the transforming growth factor beta signaling pathway |
Q42776997 | RNA Seq profiling reveals a novel expression pattern of TGF-β target genes in human blood eosinophils. |
Q34623170 | Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transition |
Q39322616 | Regulation of S100A2 expression by TGF-β-induced MEK/ERK signalling and its role in cell migration/invasion. |
Q28246772 | Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy |
Q35672763 | Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis |
Q39540430 | Role of TGF-β and BMP7 in the pathogenesis of oral submucous fibrosis. |
Q30818986 | Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous Oral Submucous Fibrosis |
Q39891539 | Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells |
Q24319956 | SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells |
Q91656912 | Subendothelial stiffness alters endothelial cell traction force generation while exerting a minimal effect on the transcriptome |
Q30597668 | TGF-β regulates LARG and GEF-H1 during EMT to affect stiffening response to force and cell invasion. |
Q39669856 | The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells. |
Q48291586 | The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer |
Q39434447 | The influence of platelet membranes on tumour cell behaviour. |
Q43031049 | The kinase PKCα selectively upregulates interleukin-17A during Th17 cell immune responses |
Q38715434 | Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells |
Q35893267 | Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages |
Q92995130 | Transcriptional profiling of corneal stromal cells derived from patients with keratoconus |
Q34999194 | Transforming growth factor β signaling upregulates the expression of human GDP-fucose transporter by activating transcription factor Sp1. |
Q37263939 | Transforming growth factor-beta1 expression is up-regulated in maturation-stage enamel organ and may induce ameloblast apoptosis |
Q36703594 | Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation. |
Q34448186 | Vicious cycle of TGF-β signaling in tumor progression and metastasis |
Q47302859 | microRNA-145 Antagonism Reverses TGF-β Inhibition of F508del CFTR Correction in Airway Epithelia. |
Search more.